Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-581067
Filing Date
2016-05-06
Accepted
2016-05-06 09:05:31
Documents
51
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d159564d10q.htm 10-Q 294931
2 EXHIBIT 31.1 d159564dex311.htm EX-31.1 9192
3 EXHIBIT 31.2 d159564dex312.htm EX-31.2 9204
4 EXHIBIT 32.1 d159564dex321.htm EX-32.1 4846
  Complete submission text file 0001193125-16-581067.txt   2710957

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ampe-20160331.xml EX-101.INS 398661
6 XBRL TAXONOMY EXTENSION SCHEMA ampe-20160331.xsd EX-101.SCH 43300
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ampe-20160331_cal.xml EX-101.CAL 68464
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ampe-20160331_def.xml EX-101.DEF 134938
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ampe-20160331_lab.xml EX-101.LAB 351148
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ampe-20160331_pre.xml EX-101.PRE 237896
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 161626061
SIC: 2834 Pharmaceutical Preparations